Drug Deaths | 2008 Latest News
Here are the latest news about drug deaths – deaths in 2008 due to ingestion of prescription medication. Prescription Drugs normally considered “safe” by the medical community may have some serious side effects and sometimes cause deaths.
As a matter of policy, we do not repeat the same story from various websites twice to avoid information overload unless the story offers significantly new information on the drug deaths which may be of interest to our readers.
We do not cover deaths due to consumption of narcotic drugs or substance abuse in this page.
Stay informed of side effects on approved medicines and medical procedures. Do not rely solely on your doctors’ advice when taking drug prescriptions. Do your own research, inform prescription drug users and help avoid drug deaths.
Links to news and institutional reports at this site (below) will keep you informed of the latest drug deaths (other than statins and other cholesterol drugs which are covered in another page on this site). This page will be updated almost daily or when there are news-breaking articles posted on the Internet, so use our RSS feed or bookmark us for regular updates.
♣♣♣♣♣
Ex-Drug Sales Rep Tells All. Former Eli Lilly Rep Says He Wined and Dined Doctors to Make a Sale. During their five-week training class, Ahari claims that instructors teach sales tactics, including how to exceed spending limits for important clients, being generous with free samples to leverage sales, using friendships and personal gifts to foster a “quid pro quo” relationship, and how to exploit sexual tension. —– (ABC News, 12 March 2008)
♣
Sanofi diet drug misses mark in heart study. Sanofi-Aventis SA’s weight-loss drug Rimonabant failed to slow heart disease by a key measure in obese patients with fat around the middle, and it significantly raised the risk of anxiety and depression, U.S. researchers said. More than 40 percent of patients who took the drug, sold as Acomplia in Europe, developed psychiatric problems, and one committed suicide, the researchers told an American College of Cardiology meeting in Chicago. Rimonabant is not available in the United States after an expert panel last year recommended against its approval because of concerns over psychiatric risks. —– (Reuters, Apr 1, 2008)
♣
Drug Makers Near Old Goal: A Legal Shield For years. Johnson & Johnson obscured evidence that its popular Ortho Evra birth control patch delivered much more estrogen than standard birth control pills, potentially increasing the risk of blood clots and strokes, according to internal company documents. More than 3,000 women and their families have sued Johnson & Johnson, asserting that users of the Ortho Evra patch suffered heart attacks, strokes and, in 40 cases, death. From 2002 to 2006, the food and drug agency received reports of at least 50 deaths associated with the drug. —– (New York Times, April 6, 2008)
♣
Rank – Drug – Type – Deaths 1998-2005
1 – Oxycodone – Prescription opioid painkiller* – 5548
2 – Fentanyl – Prescription opioid painkiller* – 3545
3 – Clozapine – Antipsychotic – 3277
4 – Morphine – Prescription opioid painkiller* – 1616
5 – Acetaminophen – Over-the-counter painkiller – 1393
6 – Methadone - Prescription opioid painkiller*/addiction medication – 1258
7 – Infliximab - Immune-system modulating drug – 1228
8 – Interferon beta – Immune-system modulating drug – 1178
9 – Risperidone – Antipsychotic – 1093
10- Etanercept – Immune-system modulating drug – 1034
Source: Moore TJ et al., Serious Adverse Drug Events Reported to the Food and Drug Administration, 1998-2005, Archives of Internal Medicine, Sept. 10., 2007; 167 (16): 1752-1759 —– (WXii, 24 March 20008)
FDA Looking At Diabetic Foot Drug and HIV Drugs. The Food and Drug Administration said Thursday it’s conducting a safety review of Regranex, a Johnson & Johnson (JNJ) becaplermin gel approved to treat diabetic foot and leg ulcers after a study suggested the product might increase the risk of cancer-related deaths. The study showed patients who were prescribed Regranex three or more times had an increase in the number of cancer-related deaths compared to those not receiving the product.
Separately, the FDA said it was also looking at HIV drugs, Ziagen, by GlaxoSmithKline (GSK), and Bristol-Myers Squibb’s (BMY) Videx to see if the drugs increase the risk for heart attacks. The FDA said an analysis from a recently published study about heart attack risk is “incomplete,” but is currently evaluating the “overall risks and benefits” of the drugs. —–(CNN Money, March 27, 2008)
Study finds 98% of child drug trials lack independent safety checks. The team found that children experienced adverse effects caused by the drugs in a third of the trials – nearly 37%. In 11%, side-effects were moderate or severe and even sometimes life-threatening. Deaths were highest in trials involving premature babies – who are often very sick. There were also deaths in trials of drugs for infectious diseases, neurology, and respiratory and kidney problems. —– (The Guardian, UK, March 19 2008)
Adverse Drug Events (ADEs) Result in More than 770,000 Injuries and Deaths Each Year and Cost up to $5.6 Million per Hospital, Depending on Size. —– (Business Wire, March 19, 2008)
FDA calls Medtronic drug pump warning Class I. Medtronic Inc said on Wednesday that U.S. regulators classified its move to inform physicians about an increase in the rate of inflammatory mass cases in patients receiving drugs through the company’s implantable infusion pumps as a Class I recall. The Food and Drug Administration defines a Class I recall as a situation in which there is a reasonable probability that use of the product will cause injury or death. —– (Reuters, Mar 19, 2008)
Data shows more deaths with Medtronic’s AneuRx: FDA. “We now calculate, based on the latest information supplied by Medtronic, a mortality rate associated with the initial surgery of 2.3 (percent) instead of the 1.5 (percent) originally calculated for the AneuRx patients,” the FDA said. AneuRx is a stent graft system, which treats artery bulges in the abdomen. Medtronic spokesman Daniel Beach added the deaths cited by the FDA were 13 out of 931 patients the agency studied. Other factors affecting death rates besides the device, including “poor follow-up, patients refusing treatment, and an elderly patient population,” he added. The agency earlier warned of other serious complications in patients receiving the product, including rupture. —– (Reuters, Mar 18, 2008)
♣
Watchdog voices dismay at failure to police industry. GlaxoSmithKline (GSK) could not be prosecuted for concealing results which proved the antidepressant Seroxat caused children to become suicidal because the law only obliges companies to hand over safety data from trials when drugs are being licensed. That loophole will now be closed. Seroxat is licensed for adults but not for children, even though doctors were prescribing it for up to 8,000 under-18s by 2003. Doctors can prescribe unlicensed drugs on their own responsibility. —– (The Guardian UK, March 07, 2008)
Drug Company Rapped Over Teen Deaths. Glaxosmithkline submitted information about the drug Seroxat to British regulators in May 2003 – and regulators say they are still “concerned” that GSK could have submitted the information earlier. The information showed the drug Seroxat was ineffective in young people under the age of 18 – and that there was also an increased risk of suicidal behavior. —– (Staff Nurse, March 7th 2008)
♣
Drug regulator keeps watch on flu drug. Australia’s drug regulator will monitor the safety of the flu drug Tamiflu in the wake of label updates warning of possible delirium and abnormal behavior. US regulators and the pharmaceutical company Roche have warned doctors of psychiatric events, some of which resulted in death, in patients taking the medication. Tamiflu and another drug, Relenza, are used widely to treat influenza A and B viruses in the early stage of infection. Governments worldwide have also been stockpiling both drugs as a first line of defense in case the bird flu virus sparks a human influenza pandemic. —– (The Age, Australia, March 5, 2008)
FDA requests more safety data on asthma drugs. The drugs, known as long-acting beta agonists, include Glaxo’s Advair and Serevent, Novartis AG’s Foradil, and AstraZeneca Plc’s Symbicort. They are used to treat asthma and other respiratory conditions. Concerns about the class of drugs date back to 2005, when the FDA asked makers to add new warnings that the medicines may increase the risk of asthma-related deaths. Other manufacturers include Mylan Inc, which sells Perforomist, and Sepracor Inc, maker of Brovana —– (Reuters, March 5, 2008)
♣
Flood of drugs, little oversight. Three patients had become ill after taking the blood-thinning drug Heparin. One had developed the same reaction during a dialysis treatment in November. Minutes after dialysis needles punctured their veins, the boys’ lips and eyelids swelled. Their blood pressure dropped, and their heartbeats raced at dangerous levels. A close look at the FDA’s resources and inspection record paints a picture of an agency struggling to keep pace. Although its officials insist the agency inspects every foreign plant sending medical products to the U.S., the agency’s own data make it appear unlikely. —– (Chicago Tribune, March 2, 2008)
♣
Savient Updates on Deaths From Trials. Savient Updates on Patient Deaths, Safety Results From Trial With Experimental Drug Puricase. Puricase is intended for use in gout patients who have already failed a prior treatment. The condition, caused by excessive amounts of uric acid, is a severe form of arthritis and causes sudden pain and swelling in joints. —– (CNN Money, February 29, 2008)
Rezulin suit disruptive, Pfizer tells US high court. Rezulin, a withdrawn diabetes drug first approved in 1996, was pulled from the market in March 2000 after about 100 people who took the medicine (Rezulin) needed liver transplants or died from acute liver failure. —– (Reuters, Feb 25, 2008)
♣
Controversial sleeping pill faces regulator’s scrutiny. The Therapeutic Goods Administration is looking at whether the controversial sleeping pill Stilnox should be reclassified as drug of abuse. There have been allegations that Stilnox is linked to people sleepwalking to their deaths. The National Drugs and Poisons Committee is meeting in Sydney this week to consider bringing Stilnox into line with more addictive drugs, such as morphine. —– (ABC News, 19 February , 2008)
♣
Deadly Combinations. The drugs that are killing the most people right now didn’t originate on the street, but with a prescription. Statewide (Florida), prescription drug overdoses caused 1,720 deaths in 2006, up about 40 percent from just three years earlier. In 2007, the state was on a pace of about 2,000 deaths. Prescription opioid painkillers and anti-anxiety drugs mentioned causing these deaths include – Methadone, Xanax, Valium, OxyContin, Oxycodone, Fentanyl —– (St Petersburg Times, February 17, 2008)
China doesn’t check plants that make U.S. drugs. This week, a Chinese factory was identified as the source of an ingredient linked to a potentially deadly allergic reaction in a blood thinner sold by Deerfield-based Baxter International Inc. Waunakee, Wis.-based Scientific Protein Laboratories owns the factory outside of Shanghai and supplies the active ingredient, derived from an enzyme in pig intestines, in the thinner known as Heparin. Baxter processes, sterilizes and packages the drug for U.S. distribution. Concerns over inspection standards in China’s drug industry are particularly acute at a time when the country has emerged as the top supplier of active ingredients in pharmaceuticals. China also is making a big push into production of generic drugs, a market India has dominated. —– (Chicago Tribune, February 16, 2008)
♣
Researcher: FDA Was Too Slow On Trasylol. Tells 60 Minutes He Estimates 22,000 Lives Could Have Been Saved. —– (CBS News, 16 Feb 2008)
♣
Study: GSK vaccine may increase risk of convulsion, death. GlaxoSmithKline’s rotavirus vaccine, called Rotarix, is associated with an increased risk of convulsions and pneumonia-related deaths in children taking it, according to a review by the U.S. Food and Drug Administration. —– (Triangle Business Journal, February 15, 2008)
Pain-relief patch recalled due to potentially fatal leak. “Fentanyl (Gel) is a potent opioid analgesic with high desirability as a drug of abuse,” the study concluded. The synthetic opioid is considered several times more potent than heroin. —– (National Post, February 15, 2008)
Baxter Halts Heparin Production Amid Reactions – an injectable blood thinner.—–(CNN Money, 11 Feb 2008)
Oxycodone linked to two deaths. Oxycodone is a Schedule II narcotic prescribed as a painkiller for moderate to severe ongoing pain. —–(Courier News, February 11, 2008)
Methadone Deaths Gain Attention Of Medical Examiners (used to treat heroin addiction). —– (MSNBC, 9 Feb 2008)
♣
FDA warns of deaths in kids treated with Botox. —– The nine most terrifying words. 100,000 people a year in this country die from pharmaceutical side effects. —– (The Oregonian February 06, 2008)
♣
GPs have got Britain ‘hooked on painkillers‘· Inquiry slams mis-prescribing of drugs · Doctors ‘ignoring official guidelines’. —– (The Observer, UK, February 10 2008)
FDA says 23 deaths linked to unapproved drug : injectable anti-gout drug – Colchicine —– (Reuters India, 7 Feb 2008)
Deaths Halt Part of Large Diabetes Trial : Avandia (rosiglitazone) linked to higher risk of heart attack —— (Washington Post, 6 Feburary 2008)
Study: Heart attacks, deaths rise after Plavix stopped. —–(Dallas Morning News, February 5, 2008)
Drug experts tackle trouble with medication names —– (Newsday, 4 February 2008)
Anti-fungal tablet linked to liver deaths —– (Herald Sun Australia, February 04, 2008)
Daiichi Sankyo Co.’s drug Injectafer should be sold in the U.S. as a backup treatment for iron deficiency anemia, a panel of U.S. advisers recommended, even though regulators had expressed concern about safety risks. —– (Bloomberg, 2 Feburary 2008)
More money, less health—–(Baltimore Sun, 29 January 2008)
Drug-name mix-ups hurt patients, getting worse. The top 10 drugs sold in the United States in 2006 all made the mix-up list—–(Reuters, 29 January 2008)
Coroner warns against flu drug overdose (Guaifenesin, Dextromethorphan, Ephedrine and Pseudoephedrine). The first one is an expectorant found in cough syrup and the others are decongestants usually found in caplets to cure the flu.—–(OttawaCitizen.com, Canada, 29 January 2008)
Ambien Linked to 6 UK Fatalities, Possible Suspect in Heath Ledger Death (sleeping pill trade name Zolpidem in the United States & Stilnoct in UK) —–(News Inferno, UK, 28 January 2008)
♣
Two Women Die After Receiving Cervical Cancer Vaccine - marketed under the name Gardasil, in Germany and Austria, respectively—–(FoxNews, 25 January 2008)
UPDATE 1-US group wants Botox warning after 16 death reports—–(Reuters, 24 January 2008)
Is Your Doctor Prescribing Placebos?—–(Time, 3 January 2008)
Prescription drug deaths double in a decade—–(Telegraph UK, 24 October 2007)
♣
Watch this interesting video Big Bucks, Big Pharma – Marketing Disease, Pushing Drugs:
♣
© http://teamrich.wordpress.com 2008 – drug deaths 2008



